Press Release Distribution
For Immediate Release: June 18, 2020 Today, the U.S. Food and Drug Administration approved Crysvita (burosumab-twza) injection to treat patients age two and older with tumor-induced osteomalacia (TIO), a rare…
Pharmaceutical company Novartis Pharmaceuticals Corporation (Novartis), based in East Hanover, New Jersey, has agreed to pay over $642 million in separate settlements resolving claims that it violated the False Claims…
For Immediate Release: June 23, 2020 The U.S. Food and Drug Administration today launched Project Patient Voice, an initiative of the FDA’s Oncology Center of Excellence (OCE). Through a new…
The U.S. Food and Drug Administration today approved Fintepla (fenfluramine), a Schedule IV controlled substance, for the treatment of seizures associated with Dravet syndrome in patients age 2 and older.…
A federal grand jury in Honolulu, Hawaii, returned a six-count indictment against three former correctional officers — Jason Tagaloa, 29, Craig Pinkney, 36, and Jonathan Taum, 48 — for their…
For Immediate Release: June 29, 2020 Español Today, the U.S. Food and Drug Administration approved Phesgo—a combination of pertuzumab, trastuzumab and hyaluronidase–zzxf—for injection under the skin to treat adult patients…
Attorney General William P. Barr has issued the following statement: “I commend Police Chief Carmen Best for her courage and leadership in restoring the rule of law in Seattle. For…
For Immediate Release: June 29, 2020 Español Today, the U.S. Food and Drug Administration approved Keytruda (pembrolizumab) for intravenous injection for the first-line treatment of patients with unresectable or metastatic…